Cargando…
Effect of Rivaroxaban and Clopidogrel Combination Therapy on In-Stent Responses After Everolimus-Eluting Stent Implantation in a Porcine Coronary Model
Aim: According to recent clinical trials, a combination of direct oral anticoagulants with antiplatelet drugs is often recommended for atrial fibrillation patients who receive drug-eluting stents (DESs). Although the optimal combination comprises direct factor Xa inhibitors and a P2Y (12) receptor a...
Autores principales: | Kitano, Daisuke, Migita, Suguru, Li, Yuxin, Takahashi, Rie, Taniguchi, Yoshiki, Kurosawa, Takafumi, Sudo, Mitsumasa, Haruta, Hironori, Hiro, Takafumi, Takayama, Tadateru, Mitsumata, Masako, Matsumoto, Taro, Okumura, Yasuo, Hirayama, Atsushi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Japan Atherosclerosis Society
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8737068/ https://www.ncbi.nlm.nih.gov/pubmed/33208566 http://dx.doi.org/10.5551/jat.56549 |
Ejemplares similares
-
Everolimus-eluting coronary stents
por: Saez, Alejandro, et al.
Publicado: (2010) -
Stent Fracture after Everolimus-Eluting Stent Implantation
por: Almasood, Ali S., et al.
Publicado: (2011) -
Early definite stent thrombosis with everolimus-eluting stents
por: Naito, Ryo, et al.
Publicado: (2015) -
Everolimus-eluting stents in interventional cardiology
por: Townsend, Jacob C, et al.
Publicado: (2012) -
A meta-analysis of everolimus-eluting stents versus sirolimus-eluting stents and paclitaxel-eluting stents in diabetic patients
por: Ouyang, Hang, et al.
Publicado: (2021)